Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 612
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT02637856 A Study of Ocrelizumab in Participants With Relapsing Remitting Multipl… |
Ocrelizumab | SEP | Phase 3 | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States, Canada · Advanced Neurology of Colorad… | 2016-02-11 → 2019-05-03 | Ouvrir |
| NCT07037966 Advancing Portable Brain Imaging: The NextMRI Project's Role in Revolut… |
MRI | SEP | Non applicable | COMPLETED | En attente / non publié | National Institute of Neurologica… | Spain · Hospital Universitario y Politécnico La Fe, V… | 2025-11-07 → 2026-09-01 | Ouvrir |
| NCT04096443 Oral FMT (Fecal Microbial Transplant) in Subjects With Multiple Scleros… |
Fecal microbial transplant (FMT) | SEP | Phase 1 | COMPLETED | En attente / non publié | Griffin Hospital | United States · Griffin Hospital, Derby, United States | 2019-10-28 → 2024-12-30 | Ouvrir |
| NCT04601233 Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis |
XYOSTED 75 milligram (mg) in 0.5 … | SEP | Phase 4 | WITHDRAWN | En attente / non publié | Tulane University | United States · LSU Health Multispecilaity Clinics, N… | 2026-06 → 2026-09-30 | Ouvrir |
| NCT07028879 HCB_MS — Effectiveness of a One-year Group Program for Fatigue Manageme… |
Fatigue management program | SEP | Non applicable | COMPLETED | En attente / non publié | Hospital Clinic of Barcelona | Spain · Hospital Clinic de Barcelona, Barcelona, Spain | 2025-03-13 → 2026-09-13 | Ouvrir |
| NCT07472413 Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Pr… |
Cetirizine | SEP | Phase 3 | NOT_YET_RECRUITING | En attente / non publié | University of Miami | United States · UHealth Boca Raton, Boca Raton, Unite… | 2026-11-01 → 2028-07-01 | Ouvrir |
| NCT03109288 Targeting Residual Activity By Precision, Biomarker-Guided Combination … |
Cilostazol | SEP | Phase 1/2 | RECRUITING | En attente / non publié | National Institute of Allergy and… | United States · National Institutes of Health Clinica… | 2017-08-11 → 2029-01-01 | Ouvrir |
| NCT05201638 ENSURE-2 — Study to Evaluate the Efficacy, Safety and Tolerability of I… |
IMU-838 tablets | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Immunic AG | United States, Armenia, Bosnia and Herzegovina, Eston… | 2022-01-12 → 2033-10 | Ouvrir |
| NCT05134441 ENSURE-1 — Study to Evaluate the Efficacy, Safety, and Tolerability of … |
IMU-838 tablets | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Immunic AG | United States, Albania, Algeria, Bulgaria, Georgia, G… | 2021-11-18 → 2033-09 | Ouvrir |
| NCT06926985 An Exploratory Clinical Study of Anti-CD19/BCMA Chimeric Antigen Recept… |
anti-CD19/BCMA CAR NK cells | SEP | Phase 1 | WITHDRAWN | En attente / non publié | Jieyang People's Hospital | China · Jieyang People's Hospital, Jieyang, China | 2025-07-30 → 2027-04-30 | Ouvrir |
| NCT06167785 ZeTA — A Study to Evaluate Zanubrutinib and Tislelizumab in Progressive… |
Tislelizumab | SEP | Phase 2 | RECRUITING | En attente / non publié | University Health Network, Toronto | Canada · University Health Network (UHN), Toronto, Ca… | 2025-06-04 → 2029-12 | Ouvrir |
| NCT02945215 A Study to Assess the Pharmacokinetics and Safety of Recombinant Human … |
IBI301 | SEP | Phase 1 | COMPLETED | En attente / non publié | Innovent Biologics (Suzhou) Co. L… | China · Beijing Cancer Hospital, Beijing, China | Har… | 2016-12-13 → 2019-10-16 | Ouvrir |
| NCT03984448 Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Ch… |
Biospecimen Collection | SEP | Phase 2/3 | ACTIVE_NOT_RECRUITING | En attente / non publié | City of Hope Medical Center | United States · Abbott-Northwestern Hospital, Minneap… | 2019-10-22 → 2028-04-01 | Ouvrir |
| NCT05178836 A Phase II Study to Evaluate the Efficacy and Safety of F520 Combined W… |
F520+F007 | SEP | Phase 2 | UNKNOWN | En attente / non publié | Shandong New Time Pharmaceutical … | Non communiqué | 2022-01-01 → 2023-12-31 | Ouvrir |
| NCT07528118 Comparison of Acetaminophen With Aminophylline and Aminophylline With D… |
Inj Aminophylline 100mg with Inj … | SEP | Phase 2 | COMPLETED | En attente / non publié | Sargodha Medical College | Pakistan · Dr.Faisal Masood Teaching Hospital, Sargod… | 2023-08-01 → 2024-07-08 | Ouvrir |
| NCT04151381 The Effect of Preoperative Aminophylline |
Aminophylline | SEP | Phase 1 | UNKNOWN | En attente / non publié | Thies Schroeder | Egypt · Beni-Suef University Hospital, Banī Suwayf, E… | 2019-11 → 2019-12 | Ouvrir |
| NCT01240824 Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bla… |
Aminophylline | SEP | Phase 1 | COMPLETED | En attente / non publié | Thies Schroeder | United States · University of Virginia Urology Depart… | 2010-07 → 2011-02 | Ouvrir |
| NCT04551170 Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Yea… |
Theophylline | SEP | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Massachusetts General Hospital | United States · Vanderbilt University Medical Center,… | 2020-07-13 → 2026-12-31 | Ouvrir |
| NCT01794780 A 1-year Multi-center, Prospective, Cohort Study in Patients With Chron… |
LABA based treatment: indacaterol | SEP | Phase 4 | COMPLETED | En attente / non publié | Novartis Pharmaceuticals | China · Novartis Investigative Site, Beijing, China |… | 2013-02-05 → 2015-05-25 | Ouvrir |
| NCT01017939 A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone Wi… |
Abiraterone acetate | SEP | Phase 1 | COMPLETED | En attente / non publié | Janssen Research & Development, L… | United States, Canada · BC Cancer Agency, Vancouver, … | 2010-01 → 2012-04 | Ouvrir |
| NCT02340520 Enhancement of Corticosteroid Efficacy in COPD |
Theophylline | SEP | Phase 3 | COMPLETED | En attente / non publié | Massachusetts General Hospital | United States · UConnHealth, Farmington, United States | 2014-12 → 2016-08 | Ouvrir |
| NCT04428476 HOPE-2-OLE — Open-label Extension of the HOPE-2 Trial |
Deramiocel (CAP-1002) | Myopathies | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Capricor Inc. | United States · Children's Hospital Colorado, Aurora,… | 2020-08-05 → 2027-03 | Ouvrir |
| NCT07748793 ASSET — Autologous Fat Grafting for the Treatment of Chronic Tendinopat… |
Adipose Stem/Stromal Cells for En… | Myopathies | Non applicable | RECRUITING | En attente / non publié | Weill Medical College of Cornell … | United States · Department of Rehabilitation Medicine… | 2026-10-31 → 2028-07 | Ouvrir |
| NCT02966665 : Vascular Function in Health and Disease |
BH4, L-NMMA, Vitamin C, Vitamin E… | Hypertension | Phase 1 | RECRUITING | En attente / non publié | D. Walter Wray | United States · University of Utah, Salt Lake City, U… | 2008-09 → 2030-08 | Ouvrir |
| NCT03332121 B001 in Patients With CD20 Positive B-cell Non Hodgkin's Lymphoma |
B001 | SEP | Phase 1 | COMPLETED | En attente / non publié | Shanghai Pharmaceuticals Holding … | China · Institute of Hematology and Blood Disease Hos… | 2018-03-22 → 2021-02-28 | Ouvrir |